+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients



Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients



Oncotarget 7(34): 55890-55899



Epidermal growth factor receptor (EGFR) and its ligands amphiregulin (AREG) and epiregulin (EREG) play a central role in the development of colorectal cancer, but the prognostic values of AREG and EREG are controversial. We conducted a meta-analysis of studies that investigated AREG and/or EREG mRNA levels in primary tumors to determine their prognostic value in metastatic colorectal cancer (mCRC). In addition, RAS status was assessed. Relevant articles were identified by searching the EMBASE, PubMed, and Cochrane Library databases. Hazard ratios (HR) with 95% confidence intervals (CIs) were calculated using a random-effects model. Nine studies involving 2167 patients were included in this meta-analysis. High AREG expression was associated with longer overall survival (OS) and progression-free survival (PFS). High EREG expression was also associated with prolonged OS and PFS. In RAS wild-type (WT) patients who received anti-EGFR therapy, high AREG and EREG expression was associated with longer OS. Our results indicate that high AREG and EREG mRNA expression are independent favorable prognostic biomarkers in mCRC. The expression of these ligands should be considered when evaluating prognoses in RAS-WT patients receiving anti-EGFR therapy.

(PDF emailed within 1 workday: $29.90)

Accession: 058637613

Download citation: RISBibTeXText

PMID: 27344184


Related references

Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. Journal of Clinical Oncology 27(30): 5068-5074, 2009

Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial). International Journal of Cancer 138(3): 739-746, 2016

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. Journal of Clinical Oncology 25(22): 3230-3237, 2007

Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases. Bmc Cancer 12: 88, 2012

Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab. Head and Neck 2018, 2018

Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy. Molecular Diagnosis and Therapy 19(6): 397-408, 2016

Levels of amphiregulin and epiregulin expression correlate with overall survival in colorectal cancer treated with cetuximab. 2007

Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer. JAMA Oncology 2016, 2016

Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer. International Journal of Cancer 2018, 2018

Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics. Onkologie 33(7): 353-358, 2010

CEACAM5 mRNA in blood as prognostic biomarker of early recurrence in liver metastatic colorectal cancer patients. European Journal of Surgical Oncology 44(4): 554-555, 2018

Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Research 20(1a): 91-95, 2000

Prognostic role of Aurora-A expression in metastatic colorectal cancer patients. Journal of B.U.On. 19(3): 686-691, 2014

Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer. Brazilian Journal of Medical and Biological Research 46(3): 306-310, 2015

Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer. European Journal of Surgical Oncology 31(8): 863-868, 2005